Trump admin mulls 'severe restrictions' on US pharmas licensing Chinese meds: NYT – Fierce Biotech

  1. Trump admin mulls ‘severe restrictions’ on US pharmas licensing Chinese meds: NYT  Fierce Biotech
  2. U.S. Drugmakers Warn White House of Chaos as Trump Weighs Curbs on China  The New York Times
  3. China Drugmaker Stocks Drop on Report of Potential Trump Curbs  Bloomberg.com
  4. Rumored Trump Move Rattles China-Based Biotech Stocks  Investor’s Business Daily
  5. Hong Kong stocks slip from 4-year high amid fears of US sanctions on drug makers  South China Morning Post

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *